HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.

Abstract
Pre-clinical and clinical studies indicated that a blockade of the NMDA receptor complex creates new opportunities for the treatment of affective disorders, including depression. The aim of the present study was to assess the influence of traxoprodil (10 mg/kg) on the activity of desipramine (10 mg/kg), paroxetine (0.5 mg/kg), milnacipran (1.25 mg/kg), and bupropion (10 mg/kg), each at sub-therapeutic doses. Moreover, brain levels of traxoprodil and tested agents were determined using HPLC. The obtained results were used to ascertain the nature of occurring interaction between traxoprodil and studied antidepressants. The experiment was carried out on naïve adult male Albino Swiss mice. Traxoprodil and other tested drugs were administered intraperitoneally. The influence of traxoprodil on the activity of selected antidepressants was evaluated in forced swim test (FST). Locomotor activity was estimated to exclude false positive/negative data. To assess the influence of traxoprodil on the concentration of used antidepressants, their levels were determined in murine brains using HPLC. Results indicated that traxoprodil potentiated activity of all antidepressants examined in FST and the observed effects were not due to the increase in locomotor activity. Only in the case of co-administration of traxoprodil and bupropion, increased bupropion concentrations in brain tissue were observed. All tested agents increased the traxoprodil levels in the brain. Administration of a sub-active dose of traxoprodil with antidepressants from different chemical groups, which act via enhancing monoaminergic transduction, caused the antidepressant-like effect in FST in mice. The interactions of traxoprodil with desipramine, paroxetine, milnacipran, and bupropion occur, at least partially, in the pharmacokinetic phase.
AuthorsWeronika Stasiuk, Aleksandra Szopa, Anna Serefko, Elżbieta Wyska, Katarzyna Świąder, Jarosław Dudka, Piotr Wlaź, Ewa Poleszak
JournalJournal of neural transmission (Vienna, Austria : 1996) (J Neural Transm (Vienna)) Vol. 124 Issue 3 Pg. 387-396 (03 2017) ISSN: 1435-1463 [Electronic] Austria
PMID27900470 (Publication Type: Journal Article)
Chemical References
  • Antidepressive Agents
  • Cyclopropanes
  • Excitatory Amino Acid Antagonists
  • NR2B NMDA receptor
  • Piperidines
  • Receptors, N-Methyl-D-Aspartate
  • Bupropion
  • Paroxetine
  • traxoprodil mesylate
  • Milnacipran
  • Desipramine
Topics
  • Analysis of Variance
  • Animals
  • Antidepressive Agents (pharmacokinetics, pharmacology)
  • Brain (drug effects, metabolism)
  • Bupropion (pharmacokinetics, pharmacology)
  • Chromatography, High Pressure Liquid
  • Cyclopropanes (pharmacokinetics, pharmacology)
  • Depressive Disorder (drug therapy, metabolism)
  • Desipramine (pharmacokinetics, pharmacology)
  • Disease Models, Animal
  • Drug Interactions
  • Excitatory Amino Acid Antagonists (pharmacokinetics, pharmacology)
  • Injections, Intraperitoneal
  • Male
  • Mice
  • Milnacipran
  • Motor Activity (drug effects)
  • Paroxetine (pharmacokinetics, pharmacology)
  • Piperidines (pharmacokinetics, pharmacology)
  • Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: